Vaxcyte (PCVX) Stock Price Target 2026

The average analyst price target for Vaxcyte is $122.18, 97.1% above the current price. Of 9 analysts, 8 rate it Buy and 1 Hold. Targets range from $38 to $175. The latest change came on Oct 5, 2026, when Needham raised its price target on Vaxcyte from $110 to $122 and kept a Buy rating.

The Average Analyst Price Target for Vaxcyte is $122.18.

Price Target Range — 12 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Hold

Consensus RatingBuy# Analysts9Avg. Consensus PT$122.18Upside to Avg. PT+97.1%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Vaxcyte Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	Cantor Fitzgerald	Carter Gould	Maintained	Overweight	$120
Oct 5, 2026	BTIG	Thomas Shrader	Maintained	Buy	$89
Oct 5, 2026	Needham	Joseph Stringer	PT Raise	Buy	$110→$122
Oct 5, 2026	Guggenheim	Seamus Fernandez	PT Raise	Buy	$116→$125
Sep 28, 2026	B of A Securities	Jason Gerberry	PT Cut	Buy	$133→$130
Sep 25, 2026	Needham	Joseph Stringer	Maintained	Buy	$110
Feb 26, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$85→$89
Feb 2, 2026	Guggenheim	Seamus Fernandez	Maintained	Buy	$116
Jan 7, 2026	Needham	Joseph Stringer	PT Raise	Buy	$90→$110
Nov 10, 2025	BTIG	Thomas Shrader	Maintained	Buy	$85
Oct 16, 2025	BTIG	Thomas Shrader	PT Cut	Buy	$160→$85
Sep 12, 2025	Goldman Sachs	Asad Haider	Initiate	Neutral	$38
Apr 22, 2025	Cantor Fitzgerald	Carter Gould	Initiate	Overweight	—
Apr 8, 2025	Needham	Joseph Stringer	Maintained	Buy	$90
Apr 1, 2025	Goldman Sachs	Chris Shibutani	PT Cut	Buy	$138→$100
Apr 1, 2025	B of A Securities	Jason Gerberry	PT Cut	Buy	$157→$137
Apr 1, 2025	Needham	Joseph Stringer	PT Cut	Buy	$140→$90
Mar 12, 2025	Guggenheim	Seamus Fernandez	Maintained	Buy	$160
Feb 26, 2025	Guggenheim	Seamus Fernandez	Maintained	Buy	$160
Feb 26, 2025	Needham	Joseph Stringer	Maintained	Buy	$140